Anzeige
Mehr »
Login
Dienstag, 28.05.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Silber-Tsunami voraus: Silver Storm als ultimative Investment-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema CSPC PHARMA

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04:47G Sachs Adds CSPC PHARMA TP to $10.262
04:47UBS Hikes CSPC PHARMA TP to $10.1; 1Q Results Beat2
04:47Daiwa Adds TP of CSPC PHARMA to $8; 1Q24 Results Beat2
04:47Nomura Lifts CSPC PHARMA TP to $10.07; Strong Growth Guidance Intact2
04:17BOCI Lifts CSPC PHARMA TP to $10.2 on Strong Finished Drug Sales, 1Q Results Beat2
MoCSPC PHARMA Surges 4%+ as 1Q NP Up 13%5
MoCSPC PHARMA 1Q Net Profit RMB1.613B, Up 12.9%7
MoCSPC PHARMA (01093): QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 20247
21.05.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - AMENDMENTS TO THE RULES OF THE RESTRICTED SHARE AWARD SCHEME2
17.05.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - RECOMBINANT FULLY HUMAN ANTI-BETA KLOTHO MONOCLONAL ANTIBODY DRUG (JMT202) OBTAINS CLINICAL TRIAL APPROVAL2
14.05.CSPC PHARMA (01093): DATE OF BOARD MEETING3
14.05.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PERAMIVIR INJECTION OBTAINS DRUG REGISTRATION APPROVAL1
03.05.CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURN3
26.04.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.3
25.04.CSPC PHARMA (01093): NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM2
25.04.CSPC PHARMA (01093): NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM2
25.04.CSPC PHARMA (01093): LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM1
25.04.CSPC PHARMA (01093): PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)1
25.04.CSPC PHARMA (01093): NOTICE OF ANNUAL GENERAL MEETING2
25.04.CSPC PHARMA (01093): PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, MANDATE TO GRANT OPTIONS AND RE-ELECTION OF RETIRING DIRECTORS ...4
Seite:  Weiter >>